| Financial Year |
March 31 2023 |
| Monetary Funds |
278,749,410.62 |
| Held-for-trading Financial Assets |
20,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
315,077,447.17 |
| Advances to Suppliers |
69,747,924.08 |
| Other Receivables |
22,150,057.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
106,342,258.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
46,698,695.91 |
| Total Current Assets |
858,765,793.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
316,336,090.30 |
| Investment Properties |
-- |
| Fixed Assetes |
12,411,860.00 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
56,953,757.20 |
| R&D expenses |
16,246,964.60 |
| Goodwill |
3,878,999.54 |
| Long-Term Deferred and Prepaid Expenses |
1,136,910.75 |
| Deferred Income Tax Assets |
47,987,091.88 |
| Other Non-Current Assets |
3,378,209.81 |
| Sub-Total of Non-Current Assets |
513,165,982.50 |
| Total Assets |
1,371,931,776.27 |
| Short-Term Loans |
313,914,284.16 |
| Trading Financial liabilities |
-- |
| Notes Payable |
21,181,366.45 |
| Accounts Payable |
67,441,394.10 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,570,446.07 |
| Taxes Payable |
28,173,196.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
55,049,106.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,044,164.87 |
| Other Current Liabilities |
5,839,095.98 |
| Sub-Total of Current Liabilities |
574,624,338.36 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,969,919.55 |
| Deferred Income Tax Liabilities |
1,359,644.89 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
13,083,239.04 |
| Total Liabilities |
587,707,577.40 |
| Paid-In Capital(Or Share Stock) |
706,640,535.00 |
| Capital Surplus |
342,960,090.34 |
| Surplus Reserve |
29,860,118.08 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-241,181,336.59 |
| Minority Stockholder's Interest |
-6,196,104.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
790,420,303.08 |
| Owner's Equity（Stockholder's Equity） |
784,224,198.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,371,931,776.27 |
